 | • レポートコード：QY20ST-06945 • 出版社/出版日：QYResearch / 2020年9月25日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥560,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥840,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,120,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界のグリピジド市場について種類別（グリピジド錠、グリピジド徐放錠、その他）、用途別（病院薬局、小売薬局、オンライン薬局）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・グリピジド市場の概要 ・世界の主要地域別グリピジド市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のグリピジド市場規模2015-2026：種類別（グリピジド錠、グリピジド徐放錠、その他） ・世界のグリピジド市場規模2015-2026：用途別（病院薬局、小売薬局、オンライン薬局） ・グリピジドの北米市場規模2015-2020 ・グリピジドのヨーロッパ市場規模2015-2020 ・グリピジドの中国市場規模2015-2020 ・グリピジドの日本市場規模2015-2020 ・グリピジドの東南アジア市場規模2015-2020 ・グリピジドのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・グリピジドの製造コスト分析 ・販売チャネル、流通業者、顧客 ・グリピジドの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Glipizide (CAS 29094-61-9) Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Glipizide (CAS 29094-61-9) market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Glipizide (CAS 29094-61-9), C21H27N5O4S, the formula weight is 445.54, and its form is white cyrstal powder.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Glipizide (CAS 29094-61-9) market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Glipizide (CAS 29094-61-9) industry.
Based on our recent survey, we have several different scenarios about the Glipizide (CAS 29094-61-9) YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ xx million in 2019. The market size of Glipizide (CAS 29094-61-9) will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Glipizide (CAS 29094-61-9) market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Glipizide (CAS 29094-61-9) market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Glipizide (CAS 29094-61-9) market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Glipizide (CAS 29094-61-9) market. The report also includes nautical information, where it shows Glipizide (CAS 29094-61-9) market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Glipizide (CAS 29094-61-9) market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Glipizide (CAS 29094-61-9) market.
Glipizide is a hypoglycemic drug for non-insulin-dependent (II) type diabetes, which is used in patients with mild to moderate non-insulin-dependent patients who fail to achieve good results with diet control alone.
Geographical Analysis:
Based on region, the global Glipizide (CAS 29094-61-9) market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Glipizide (CAS 29094-61-9) market are
Pfizer
United Laboratories
Disha Pharma
PIDI
Lukang Pharma
Jingfeng Zhiyao
Jumpcan
CCPC
Yashica Pharma
Apotex
TEVA
Segment by Type
Glipizide Tablets
Glipizide Sustained Release Tablets
Others
Segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Glipizide (CAS 29094-61-9) market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Glipizide (CAS 29094-61-9) market.
• The market share of the global Glipizide (CAS 29094-61-9) market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Glipizide (CAS 29094-61-9) market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Glipizide (CAS 29094-61-9) market.
1 Glipizide (CAS 29094-61-9) Market Overview
1.1 Glipizide (CAS 29094-61-9) Product Scope
1.2 Glipizide (CAS 29094-61-9) Segment by Type
1.2.1 Global Glipizide (CAS 29094-61-9) Sales by Type (2020-2026)
1.2.2 Glipizide Tablets
1.2.3 Glipizide Sustained Release Tablets
1.2.4 Others
1.3 Glipizide (CAS 29094-61-9) Segment by Application
1.3.1 Global Glipizide (CAS 29094-61-9) Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Glipizide (CAS 29094-61-9) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Glipizide (CAS 29094-61-9) Sales Growth Rate (2015-2026)
1.4.2 Global Glipizide (CAS 29094-61-9) Revenue and Growth Rate (2015-2026)
1.4.3 Global Glipizide (CAS 29094-61-9) Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Glipizide (CAS 29094-61-9) Industry Impact
1.5.1 How the Covid-19 is Affecting the Glipizide (CAS 29094-61-9) Industry
1.5.1.1 Glipizide (CAS 29094-61-9) Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Glipizide (CAS 29094-61-9) Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Glipizide (CAS 29094-61-9) Players to Combat Covid-19 Impact
2 Glipizide (CAS 29094-61-9) Estimate and Forecast by Region
2.1 Global Glipizide (CAS 29094-61-9) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Glipizide (CAS 29094-61-9) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Glipizide (CAS 29094-61-9) Sales Market Share by Region (2015-2020)
2.2.2 Global Glipizide (CAS 29094-61-9) Revenue Market Share by Region (2015-2020)
2.3 Global Glipizide (CAS 29094-61-9) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Glipizide (CAS 29094-61-9) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Glipizide (CAS 29094-61-9) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Glipizide (CAS 29094-61-9) Estimates and Projections (2015-2026)
2.4.2 Europe Glipizide (CAS 29094-61-9) Estimates and Projections (2015-2026)
2.4.3 China Glipizide (CAS 29094-61-9) Estimates and Projections (2015-2026)
2.4.4 Japan Glipizide (CAS 29094-61-9) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Glipizide (CAS 29094-61-9) Estimates and Projections (2015-2026)
2.4.6 India Glipizide (CAS 29094-61-9) Estimates and Projections (2015-2026)
3 Global Glipizide (CAS 29094-61-9) Competition Landscape by Players
3.1 Global Top Glipizide (CAS 29094-61-9) Players by Sales (2015-2020)
3.2 Global Top Glipizide (CAS 29094-61-9) Players by Revenue (2015-2020)
3.3 Global Glipizide (CAS 29094-61-9) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glipizide (CAS 29094-61-9) as of 2019)
3.4 Global Glipizide (CAS 29094-61-9) Average Price by Company (2015-2020)
3.5 Manufacturers Glipizide (CAS 29094-61-9) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Glipizide (CAS 29094-61-9) Players (Opinion Leaders)
4 Global Glipizide (CAS 29094-61-9) Market Size by Type
4.1 Global Glipizide (CAS 29094-61-9) Historic Market Review by Type (2015-2020)
4.1.1 Global Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
4.1.2 Global Glipizide (CAS 29094-61-9) Revenue Market Share by Type (2015-2020)
4.1.3 Global Glipizide (CAS 29094-61-9) Price by Type (2014-2020)
4.2 Global Glipizide (CAS 29094-61-9) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Glipizide (CAS 29094-61-9) Sales Forecast by Type (2021-2026)
4.2.2 Global Glipizide (CAS 29094-61-9) Revenue Forecast by Type (2021-2026)
4.2.3 Global Glipizide (CAS 29094-61-9) Price Forecast by Type (2021-2026)
5 Global Glipizide (CAS 29094-61-9) Market Size by Application
5.1 Global Glipizide (CAS 29094-61-9) Historic Market Review by Application (2015-2020)
5.1.1 Global Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
5.1.2 Global Glipizide (CAS 29094-61-9) Revenue Market Share by Application (2015-2020)
5.1.3 Global Glipizide (CAS 29094-61-9) Price by Application (2015-2020)
5.2 Global Glipizide (CAS 29094-61-9) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Glipizide (CAS 29094-61-9) Sales Forecast by Application (2021-2026)
5.2.2 Global Glipizide (CAS 29094-61-9) Revenue Forecast by Application (2021-2026)
5.2.3 Global Glipizide (CAS 29094-61-9) Price Forecast by Application (2021-2026)
3 North America Glipizide (CAS 29094-61-9) Market Facts & Figures
3.2 North America Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
3.3 North America Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
3.4 North America Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
4 Europe Glipizide (CAS 29094-61-9) Market Facts & Figures
4.2 Europe Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
4.3 Europe Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
4.4 Europe Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
5 China Glipizide (CAS 29094-61-9) Market Facts & Figures
5.2 China Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
5.3 China Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
5.4 China Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
6 Japan Glipizide (CAS 29094-61-9) Market Facts & Figures
6.2 Japan Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
6.3 Japan Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
6.4 Japan Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
7 Southeast Asia Glipizide (CAS 29094-61-9) Market Facts & Figures
7.2 Southeast Asia Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
8 India Glipizide (CAS 29094-61-9) Market Facts & Figures
8.2 India Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
8.3 India Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
8.4 India Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Glipizide (CAS 29094-61-9) Business
12.1 Pfizer
12.1.1 Pfizer Glipizide (CAS 29094-61-9) Corporation Information
12.1.2 Pfizer Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.1.3 Pfizer Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Glipizide (CAS 29094-61-9) Products Offered
12.1.5 Pfizer Recent Development
12.2 United Laboratories
12.2.1 United Laboratories Glipizide (CAS 29094-61-9) Corporation Information
12.2.2 United Laboratories Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.2.3 United Laboratories Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 United Laboratories Glipizide (CAS 29094-61-9) Products Offered
12.2.5 United Laboratories Recent Development
12.3 Disha Pharma
12.3.1 Disha Pharma Glipizide (CAS 29094-61-9) Corporation Information
12.3.2 Disha Pharma Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.3.3 Disha Pharma Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Disha Pharma Glipizide (CAS 29094-61-9) Products Offered
12.3.5 Disha Pharma Recent Development
12.4 PIDI
12.4.1 PIDI Glipizide (CAS 29094-61-9) Corporation Information
12.4.2 PIDI Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.4.3 PIDI Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 PIDI Glipizide (CAS 29094-61-9) Products Offered
12.4.5 PIDI Recent Development
12.5 Lukang Pharma
12.5.1 Lukang Pharma Glipizide (CAS 29094-61-9) Corporation Information
12.5.2 Lukang Pharma Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.5.3 Lukang Pharma Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Lukang Pharma Glipizide (CAS 29094-61-9) Products Offered
12.5.5 Lukang Pharma Recent Development
12.6 Jingfeng Zhiyao
12.6.1 Jingfeng Zhiyao Glipizide (CAS 29094-61-9) Corporation Information
12.6.2 Jingfeng Zhiyao Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.6.3 Jingfeng Zhiyao Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Jingfeng Zhiyao Glipizide (CAS 29094-61-9) Products Offered
12.6.5 Jingfeng Zhiyao Recent Development
12.7 Jumpcan
12.7.1 Jumpcan Glipizide (CAS 29094-61-9) Corporation Information
12.7.2 Jumpcan Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.7.3 Jumpcan Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Jumpcan Glipizide (CAS 29094-61-9) Products Offered
12.7.5 Jumpcan Recent Development
12.8 CCPC
12.8.1 CCPC Glipizide (CAS 29094-61-9) Corporation Information
12.8.2 CCPC Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.8.3 CCPC Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 CCPC Glipizide (CAS 29094-61-9) Products Offered
12.8.5 CCPC Recent Development
12.9 Yashica Pharma
12.9.1 Yashica Pharma Glipizide (CAS 29094-61-9) Corporation Information
12.9.2 Yashica Pharma Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.9.3 Yashica Pharma Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Yashica Pharma Glipizide (CAS 29094-61-9) Products Offered
12.9.5 Yashica Pharma Recent Development
12.10 Apotex
12.10.1 Apotex Glipizide (CAS 29094-61-9) Corporation Information
12.10.2 Apotex Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.10.3 Apotex Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Apotex Glipizide (CAS 29094-61-9) Products Offered
12.10.5 Apotex Recent Development
12.11 TEVA
12.11.1 TEVA Glipizide (CAS 29094-61-9) Corporation Information
12.11.2 TEVA Glipizide (CAS 29094-61-9) Business Overview and Total Revenue
12.11.3 TEVA Glipizide (CAS 29094-61-9) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 TEVA Glipizide (CAS 29094-61-9) Products Offered
12.11.5 TEVA Recent Development
13 Glipizide (CAS 29094-61-9) Manufacturing Cost Analysis
13.1 Glipizide (CAS 29094-61-9) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Glipizide (CAS 29094-61-9)
13.4 Glipizide (CAS 29094-61-9) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Glipizide (CAS 29094-61-9) Distributors List
14.3 Glipizide (CAS 29094-61-9) Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Glipizide (CAS 29094-61-9) Sales (Kg) Growth Rate by Type (2020-2026)
Table 2. Global Glipizide (CAS 29094-61-9) Sales (Kg) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Glipizide (CAS 29094-61-9) Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Glipizide (CAS 29094-61-9) Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Glipizide (CAS 29094-61-9) Players to Combat Covid-19 Impact
Table 8. Global Market Glipizide (CAS 29094-61-9) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Glipizide (CAS 29094-61-9) Sales (Kg) by Region (2015-2020)
Table 10. Global Glipizide (CAS 29094-61-9) Sales Market Share by Region (2015-2020)
Table 11. Global Glipizide (CAS 29094-61-9) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Glipizide (CAS 29094-61-9) Revenue Share by Region (2015-2020)
Table 13. Global Glipizide (CAS 29094-61-9) Sales (Kg) Forecast by Region (2021-2026)
Table 14. Global Glipizide (CAS 29094-61-9) Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Glipizide (CAS 29094-61-9) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Glipizide (CAS 29094-61-9) Revenue Share Forecast by Region (2021-2026)
Table 17. Global Glipizide (CAS 29094-61-9) (Kg) of Key Companies (2015-2020)
Table 18. Global Glipizide (CAS 29094-61-9) Sales Share by Company (2015-2020)
Table 19. Global Glipizide (CAS 29094-61-9) Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Glipizide (CAS 29094-61-9) Revenue Share by Company (2015-2020)
Table 21. Global Glipizide (CAS 29094-61-9) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glipizide (CAS 29094-61-9) as of 2019)
Table 22. Global Glipizide (CAS 29094-61-9) Average Price (USD/Kg) of Key Company (2015-2020)
Table 23. Manufacturers Glipizide (CAS 29094-61-9) Manufacturing Sites and Area Served
Table 24. Manufacturers Glipizide (CAS 29094-61-9) Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Glipizide (CAS 29094-61-9) Players
Table 27. Global Glipizide (CAS 29094-61-9) Sales (Kg) by Type (2015-2020)
Table 28. Global Glipizide (CAS 29094-61-9) Sales Share by Type (2015-2020)
Table 29. Global Glipizide (CAS 29094-61-9) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Glipizide (CAS 29094-61-9) Price (Kg) by Type (2015-2020)
Table 31. Global Glipizide (CAS 29094-61-9) Sales Share by Type (2021-2026)
Table 32. Global Glipizide (CAS 29094-61-9) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Glipizide (CAS 29094-61-9) Revenue Share by Type (2021-2026)
Table 34. Global Glipizide (CAS 29094-61-9) Price (Kg) by Type (2021-2026)
Table 35. Global Glipizide (CAS 29094-61-9) Sales (Kg) by Application (2015-2020)
Table 36. Global Glipizide (CAS 29094-61-9) Sales Share by Application (2015-2020)
Table 37. Global Glipizide (CAS 29094-61-9) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Glipizide (CAS 29094-61-9) Price (Kg) by Application (2015-2020)
Table 39. Global Glipizide (CAS 29094-61-9) Sales (Kg) by Application (2021-2026)
Table 40. Global Glipizide (CAS 29094-61-9) Sales Share by Application (2021-2026)
Table 41. Global Glipizide (CAS 29094-61-9) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Glipizide (CAS 29094-61-9) Revenue Share by Application (2021-2026)
Table 43. Global Glipizide (CAS 29094-61-9) Price (Kg) by Application (2021-2026)
Table 44. United States Glipizide (CAS 29094-61-9) Sales (Kg) by Company (2015-2020)
Table 45. United States Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
Table 46. United States Glipizide (CAS 29094-61-9) Sales (Kg) by Type (2015-2020)
Table 47. United States Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
Table 48. United States Glipizide (CAS 29094-61-9) Sales (Kg) by Application (2015-2020)
Table 49. United States Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
Table 50. Europe Glipizide (CAS 29094-61-9) Sales (Kg) by Company (2015-2020)
Table 51. Europe Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
Table 52. Europe Glipizide (CAS 29094-61-9) Sales (Kg) by Type (2015-2020)
Table 53. Europe Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
Table 54. Europe Glipizide (CAS 29094-61-9) Sales (Kg) by Application (2015-2020)
Table 55. Europe Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
Table 56. China Glipizide (CAS 29094-61-9) Sales (Kg) by Company (2015-2020)
Table 57. China Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
Table 58. China Glipizide (CAS 29094-61-9) Sales (Kg) by Type (2015-2020)
Table 59. China Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
Table 60. China Glipizide (CAS 29094-61-9) Sales (Kg) by Application (2015-2020)
Table 61. China Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
Table 62. Japan Glipizide (CAS 29094-61-9) Sales (Kg) by Company (2015-2020)
Table 63. Japan Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
Table 64. Japan Glipizide (CAS 29094-61-9) Sales (Kg) by Type (2015-2020)
Table 65. Japan Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
Table 66. Japan Glipizide (CAS 29094-61-9) Sales (Kg) by Application (2015-2020)
Table 67. Japan Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Glipizide (CAS 29094-61-9) Sales (Kg) by Company (2015-2020)
Table 69. Southeast Asia Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Glipizide (CAS 29094-61-9) Sales (Kg) by Type (2015-2020)
Table 71. Southeast Asia Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Glipizide (CAS 29094-61-9) Sales (Kg) by Type (2015-2020)
Table 73. Southeast Asia Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
Table 74. India Glipizide (CAS 29094-61-9) Sales (Kg) by Company (2015-2020)
Table 75. India Glipizide (CAS 29094-61-9) Sales Market Share by Company (2015-2020)
Table 76. India Glipizide (CAS 29094-61-9) Sales (Kg) by Type (2015-2020)
Table 77. India Glipizide (CAS 29094-61-9) Sales Market Share by Type (2015-2020)
Table 78. India Glipizide (CAS 29094-61-9) Sales (Kg) by Application (2015-2020)
Table 79. India Glipizide (CAS 29094-61-9) Sales Market Share by Application (2015-2020)
Table 80. Pfizer Corporation Information
Table 81. Pfizer Description and Business Overview
Table 82. Pfizer Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Pfizer Glipizide (CAS 29094-61-9) Product
Table 84. Pfizer Recent Development
Table 85. United Laboratories Corporation Information
Table 86. United Laboratories Description and Business Overview
Table 87. United Laboratories Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. United Laboratories Glipizide (CAS 29094-61-9) Product
Table 89. United Laboratories Recent Development
Table 90. Disha Pharma Corporation Information
Table 91. Disha Pharma Description and Business Overview
Table 92. Disha Pharma Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Disha Pharma Glipizide (CAS 29094-61-9) Product
Table 94. Disha Pharma Recent Development
Table 95. PIDI Corporation Information
Table 96. PIDI Description and Business Overview
Table 97. PIDI Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. PIDI Glipizide (CAS 29094-61-9) Product
Table 99. PIDI Recent Development
Table 100. Lukang Pharma Corporation Information
Table 101. Lukang Pharma Description and Business Overview
Table 102. Lukang Pharma Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Lukang Pharma Glipizide (CAS 29094-61-9) Product
Table 104. Lukang Pharma Recent Development
Table 105. Jingfeng Zhiyao Corporation Information
Table 106. Jingfeng Zhiyao Description and Business Overview
Table 107. Jingfeng Zhiyao Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Jingfeng Zhiyao Glipizide (CAS 29094-61-9) Product
Table 109. Jingfeng Zhiyao Recent Development
Table 110. Jumpcan Corporation Information
Table 111. Jumpcan Description and Business Overview
Table 112. Jumpcan Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 113. Jumpcan Glipizide (CAS 29094-61-9) Product
Table 114. Jumpcan Recent Development
Table 115. CCPC Corporation Information
Table 116. CCPC Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. CCPC Description and Business Overview
Table 118. CCPC Glipizide (CAS 29094-61-9) Product
Table 119. CCPC Recent Development
Table 120. Yashica Pharma Corporation Information
Table 121. Yashica Pharma Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 122. Yashica Pharma Description and Business Overview
Table 123. Yashica Pharma Glipizide (CAS 29094-61-9) Product
Table 124. Yashica Pharma Recent Development
Table 125. Apotex Corporation Information
Table 126. Apotex Description and Business Overview
Table 127. Apotex Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Apotex Glipizide (CAS 29094-61-9) Product
Table 129. Apotex Recent Development
Table . TEVA Corporation Information
Table . TEVA Description and Business Overview
Table . TEVA Glipizide (CAS 29094-61-9) Sales (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table . TEVA Glipizide (CAS 29094-61-9) Product
Table . TEVA Recent Development
Table 135. Production Base and Market Concentration Rate of Raw Material
Table 136. Key Suppliers of Raw Materials
Table 137. Glipizide (CAS 29094-61-9) Distributors List
Table 138. Glipizide (CAS 29094-61-9) Customers List
Table 139. Market Key Trends
Table 140. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 141. Key Challenges
Table 142. Research Programs/Design for This Report
Table 143. Key Data Information from Secondary Sources
Table 144. Key Data Information from Primary Sources
List of Figures
Figure 1. Glipizide (CAS 29094-61-9) Product Picture
Figure 2. Global Glipizide (CAS 29094-61-9) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Glipizide (CAS 29094-61-9) Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Retail Pharmacies Examples
Figure 8. Online Pharmacies Examples
Figure 9. Global Glipizide (CAS 29094-61-9) Sales (Kg) Growth Rate (2015-2026)
Figure 10. Global Glipizide (CAS 29094-61-9) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Glipizide (CAS 29094-61-9) Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Glipizide (CAS 29094-61-9) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Glipizide (CAS 29094-61-9) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Glipizide (CAS 29094-61-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Glipizide (CAS 29094-61-9) Sales (Kg) Growth Rate (2015-2026)
Figure 16. Europe Glipizide (CAS 29094-61-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Glipizide (CAS 29094-61-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Glipizide (CAS 29094-61-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Glipizide (CAS 29094-61-9) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Glipizide (CAS 29094-61-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Glipizide (CAS 29094-61-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Glipizide (CAS 29094-61-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Glipizide (CAS 29094-61-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Glipizide (CAS 29094-61-9) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Glipizide (CAS 29094-61-9) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Glipizide (CAS 29094-61-9) Players Market Share by Revenue in Glipizide (CAS 29094-61-9) 2015 & 2019
Figure 27. Glipizide (CAS 29094-61-9) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Glipizide (CAS 29094-61-9) Revenue Share by Type (2015-2020)
Figure 29. Global Glipizide (CAS 29094-61-9) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Glipizide (CAS 29094-61-9) Revenue Share by Application (2015-2020)
Figure 31. Global Glipizide (CAS 29094-61-9) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Glipizide (CAS 29094-61-9) Sales Market Share by Type in 2019
Figure 33. United States Glipizide (CAS 29094-61-9) Sales Market Share by Type in 2019
Figure 34. Europe Glipizide (CAS 29094-61-9) Sales Market Share by Company in 2019
Figure 35. Europe Glipizide (CAS 29094-61-9) Sales Market Share by Type in 2019
Figure 36. Europe Glipizide (CAS 29094-61-9) Sales Market Share by Application in 2019
Figure 37. China Glipizide (CAS 29094-61-9) Sales Market Share by Company in 2019
Figure 38. China Glipizide (CAS 29094-61-9) Sales Market Share by Type in 2019
Figure 39. China Glipizide (CAS 29094-61-9) Sales Market Share by Application in 2019
Figure 40. Japan Glipizide (CAS 29094-61-9) Sales Market Share by Company in 2019
Figure 41. Japan Glipizide (CAS 29094-61-9) Sales Market Share by Type in 2019
Figure 42. Japan Glipizide (CAS 29094-61-9) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Glipizide (CAS 29094-61-9) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Glipizide (CAS 29094-61-9) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Glipizide (CAS 29094-61-9) Sales Market Share by Application in 2019
Figure 46. India Glipizide (CAS 29094-61-9) Sales Market Share by Company in 2019
Figure 47. India Glipizide (CAS 29094-61-9) Sales Market Share by Type in 2019
Figure 48. India Glipizide (CAS 29094-61-9) Sales Market Share by Application in 2019
Figure 49. Pfizer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 50. United Laboratories Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. Disha Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. PIDI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Lukang Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Jingfeng Zhiyao Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Jumpcan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. CCPC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Yashica Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Apotex Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. TEVA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Key Raw Materials Price Trend
Figure 61. Manufacturing Cost Structure of Glipizide (CAS 29094-61-9)
Figure 62. Manufacturing Process Analysis of Glipizide (CAS 29094-61-9)
Figure 63. Glipizide (CAS 29094-61-9) Industrial Chain Analysis
Figure 64. Channels of Distribution
Figure 65. Distributors Profiles
Figure 66. Porter's Five Forces Analysis
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
オフロキサシン錠の世界市場レポート2020 A recently published report by QY Research titled Global Ofloxacin Tablets Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate …- イルベサルタン錠の世界市場レポート2020 A recently published report by QY Research titled Global Irbesartan Tablets Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate…
- クラリスロマイシン錠の世界市場レポート2020 A recently published report by QY Research titled Global Clarithromycin Tablets Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…
- 徐放性フィルムコーティングの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Sustained Release Film Coating market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Sustained Rele…
- ラロキシフェン塩酸塩錠の世界市場レポート2020 A recently published report by QY Research titled Global Raloxifene Hydrochloride Tablets Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically pro…